The Solid Tumor Panel is a comprehensive test designed to detect genetic alterations in 50 genes that are frequently mutated across a wide range of solid tumors. This includes but is not limited to breast, colorectal, lung, and gastric cancers.
By identifying these genetic mutations, the test helps oncologists make informed decisions about targeted therapies and personalized treatment plans. Suitable for formalin-fixed paraffin-embedded (FFPE) tissue samples, this panel provides vital insights for both newly diagnosed patients and those undergoing therapy to monitor resistance or recurrence.